arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Gevo, Inc.

GEVO
$1.20 ▼ -0.08 (-6.25%) at close
Materials ·Industrial Organic Chemicals ·USIndustrial Organic Chemicals
71 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
37
Health
Weak
Bearish
auto_awesome

Analytical Summary

Gevo, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $284.5M
Dividend Yield —
Revenue Growth 7.1% ↘
Op. Margin -369.3% ↘
ROIC -30.8% ↘
FCF / Share $-0.09 ↗
Trailing P/E —
Price / Book 1.1x
FCF Yield —
Debt / Equity 0.61
info Valuation on last close. End-of-day price, Nov 5, 2026.

71-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$46.50M
↑ +7.1% —
Net Income Profit after all expenses
$-176.94M
↓ -715.5% —
Operating Margin Operating profit as % of sales
-369.3%
↓ -3137.8% 13th
FCF / Share Free cash flow per share
$-0.09
↑ +30.9% —
Long-Term Debt Long-term obligations
$167.24M
— +0.3% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
10
Returns ↑
36
Financial Health ↑
52
Cash Quality ↓
75

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 21 years · 71 quarters